Clare Locke LLP Files Motion For Leave To File An Amicus Brief To Back Megan Thee Stallion’s Effort to Reinstate Defamation Verdict Against Milagro Cooper

Renowned defamation law firm Clare Locke LLP filed a motion for leave to file an amicus brief in support of Megan Thee Stallion's motion to reinstate the jury's defamation verdict against Milagro Cooper in her case in the Southern District of Florida. In its brief, Clare Locke explains that Florida's retraction-demand statute applies only to […]

FI DEADLINE ALERT: Fiserv, Inc. Investors Urged to Contact Kirby McInerney LLP About Class Action Lawsuit

(NYSE:FI), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Kirby McInerney LLP reminds Fiserv, Inc. (“Fiserv” or the “Company”) (NYSE: FI) investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. If you purchased or otherwise acquired Fiserv securities, have information, or would like

DAREU to Unveil Three High-Performance Gaming Peripherals at CES 2026

— Beyond product launches,DAREU is seeking global distributors to expand its footprint DAREU, the gaming peripheral brand built on the ethos “DARE TO BE YOU,” is set to present its latest lineup of gaming peripherals at CES 2026, unveiling three new products that reflect the brand's ongoing pursuit of performance, design innovation, and player-centric engineering.

Qiming Venture Partners’ Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks the largest biotech IPO on the Hong Kong stock market in 2025. With an issue price of HK$24.05per share, Insilico Medicine opened at HK$35.00per

Qiming Venture Partners’ Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks the largest biotech IPO on the Hong Kong stock market in 2025. With an issue price of HK$24.05per share, Insilico Medicine opened at HK$35.00per

Dr. Andrea Adams-Miller Highlights Growing Executive Risk as Cognitive Lapses Trigger Market and Reputational Fallout

FINDLAY, OH, Dec. 30, 2025 (GLOBE NEWSWIRE) — FINDLAY, OH – December 31, 2025 – – Dr. Andrea Adams-Miller of The RED Carpet Connection LLC is addressing a growing shift in executive advisory work as organizations increasingly treat discretion, cognitive clarity, and mental containment as leadership risk infrastructure rather than personal development. Recent events have

Dr. Andrea Adams-Miller Highlights Growing Executive Risk as Cognitive Lapses Trigger Market and Reputational Fallout

Dr. Andrea Adams-Miller Highlights Growing Executive Risk as Cognitive Lapses Trigger Market and Reputational Fallout GlobeNewswire December 31, 2025 FINDLAY, OH, Dec. 30, 2025 (GLOBE NEWSWIRE) — FINDLAY, OH – December 31, 2025 – – Dr. Andrea Adams-Miller of The RED Carpet Connection LLC is addressing a growing shift in executive advisory work as organizations

Maple Rock Capital Partners Files Early Warning Report

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Maple Rock Capital Partners Inc. (“Maple Rock“) has filed an early warning report on SEDAR+ (www.sedarplus.com) with respect to the common shares (“Shares“) of Optiva Inc. (the “Issuer“) controlled by Maple Rock and this news release is being disseminated as required by National Instrument 62â€103 – The Early

Maple Rock Capital Partners Files Early Warning Report

Maple Rock Capital Partners Files Early Warning Report GlobeNewswire December 31, 2025 TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Maple Rock Capital Partners Inc. (“Maple Rock“) has filed an early warning report on SEDAR+ (www.sedarplus.com) with respect to the common shares (“Shares“) of Optiva Inc. (the “Issuer“) controlled by Maple Rock and this news release

Scroll to Top